Oliver Kent Glass, PhD

Assistant Professor in Medicine
Campus mail 3475 Erwin Rd., Durham, NC 27710
Phone (919) 660-6672
Email address oliver.glass@duke.edu

My research interests are understanding how and why exercise is effective in chronic disease. I am interested in the unique role of skeletal muscle as a key mediator of exercise effects. 

Education and Training

  • Ph.D., Duke University, 2015

Publications

Glass, O, Radia, A, Kraus, W, and Abdelmalek, M. "Exercise Training as Treatment of Nonalcoholic Fatty Liver Disease." Journal of Functional Morphology and Kinesiology 2, no. 4 (December 2017): 35-35.

Full Text

Glass, OK, Bowie, M, Fuller, J, Darr, D, sary, JU, Boss, K, Choudhury, KR, Liu, X, Zhang, Z, Locasale, JW, Williams, C, Dewhirst, MW, Jones, LW, and Seewaldt, V. "Differential response to exercise in claudin-low breast cancer(Published online)." Oncotarget (September 19, 2017).

PMID
29254140
Full Text

Glass, OK, Ramalingam, S, and Harrison, MR. "Resistance exercise training in patients with genitourinary cancers to mitigate treatment-related skeletal muscle loss." Clin Adv Hematol Oncol 14, no. 6 (June 2016): 436-446. (Review)

PMID
27379813
Scholars@Duke

Glass, OK, Inman, BA, Broadwater, G, Courneya, KS, Mackey, JR, Goruk, S, Nelson, ER, Jasper, J, Field, CJ, Bain, JR, Muehlbauer, M, Stevens, RD, Hirschey, MD, and Jones, LW. "Effect of aerobic training on the host systemic milieu in patients with solid tumours: an exploratory correlative study." British journal of cancer 112, no. 5 (March 2015): 825-831.

PMID
25584487
Full Text

Glass, O, Inman, BA, Courneya, KS, Mackey, JR, Nelson, E, Hartman, Z, and Jones, LW. "Abstract 1376: Exercise alters breast cancer phenotype through distinct reductions in host-derived proinflammatory growth factor ligands." April 15, 2013.

Full Text

Hartman, ZC, Wei, J, Glass, OK, Guo, H, Lei, G, Yang, X-Y, Osada, T, Hobeika, A, Delcayre, A, Le Pecq, J-B, Morse, MA, Clay, TM, and Lyerly, HK. "Increasing vaccine potency through exosome antigen targeting." Vaccine 29, no. 50 (November 2011): 9361-9367.

PMID
22001882
Full Text

Hartman, ZC, Yang, X-Y, Glass, O, Lei, G, Osada, T, Dave, SS, Morse, MA, Clay, TM, and Lyerly, HK. "HER2 overexpression elicits a proinflammatory IL-6 autocrine signaling loop that is critical for tumorigenesis." Cancer Research 71, no. 13 (July 2011): 4380-4391.

PMID
21518778
Full Text

Hartman, ZC, Osada, T, Glass, O, Yang, XY, Lei, G-J, Lyerly, HK, and Clay, TM. "Ligand-independent toll-like receptor signals generated by ectopic overexpression of MyD88 generate local and systemic antitumor immunity." Cancer Research 70, no. 18 (September 7, 2010): 7209-7220.

PMID
20823152
Full Text

Hartman, ZC, Wei, J, Osada, T, Glass, O, Lei, G, Yang, X-Y, Peplinski, S, Kim, D-W, Xia, W, Spector, N, Marks, J, Barry, W, Hobeika, A, Devi, G, Amalfitano, A, Morse, MA, Lyerly, HK, and Clay, TM. "An adenoviral vaccine encoding full-length inactivated human Her2 exhibits potent immunogenicty and enhanced therapeutic efficacy without oncogenicity." Clinical Cancer Research : an Official Journal of the American Association for Cancer Research 16, no. 5 (March 2010): 1466-1477.

PMID
20179231
Full Text

Osada, T, Yang, XY, Hartman, ZC, Glass, O, Hodges, BL, Niedzwiecki, D, Morse, MA, Lyerly, HK, Amalfitano, A, and Clay, TM. "Optimization of vaccine responses with an E1, E2b and E3-deleted Ad5 vector circumvents pre-existing anti-vector immunity." Cancer Gene Ther 16, no. 9 (September 2009): 673-682.

PMID
19229288
Full Text

Pages